Catechol-O-methyltransferase inhibitors in Parkinson's disease.
Harper
J
J
Vieira
B
B
D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001577:Benzophenones / Q000008:administration & dosage / Q000009:adverse effects*; D065098:Catechol O-Methyltransferase Inhibitors; D003221:Confusion / Q000139:chemically induced; D004347:Drug Interactions; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects; D009596:Nitrophenols; D010300:Parkinson Disease / Q000188:drug therapy*; D000077867:Tolcapone
D000978:Antiparkinson Agents; D001577:Benzophenones; D065098:Catechol O-Methyltransferase Inhibitors; D004791:Enzyme Inhibitors; D009596:Nitrophenols; D007980:Levodopa; D000077867:Tolcapone